1-deoxynojirimycin has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murphy, PV; O'Boyle, KM; Zhao, Y; Zhou, Y | 1 |
Chang, J; Chrest, FJ; Mueller, RA; Partis, RA; Passaniti, A; Pili, R | 1 |
2 other study(ies) available for 1-deoxynojirimycin and Angiogenesis, Pathologic
Article | Year |
---|---|
Hybrids of 1-deoxynojirimycin and aryl-1,2,3-triazoles and biological studies related to angiogenesis.
Topics: 1-Deoxynojirimycin; Aminopeptidases; Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Cattle; Cell Cycle; Cell Line; Cell Movement; Cell Proliferation; Cyclin D1; Endothelial Cells; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Metalloendopeptidases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Stress Fibers; Triazoles | 2008 |
The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.
Topics: 1-Deoxynojirimycin; Animals; Cell Adhesion; Cell Aggregation; Cell Differentiation; Cell Division; Cells, Cultured; Chemotaxis; Endothelium; Glucosamine; Glycoconjugates; Glycoside Hydrolase Inhibitors; Glycosylation; Growth Inhibitors; In Vitro Techniques; Indolizines; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Processing, Post-Translational | 1995 |